10/06/2026
📊 Case Study: Integrated Summary of Safety for Oncology Data Pooling
Oncology programmes often require safety data to be assessed across multiple studies, patient populations, and dosing contexts.
In this case study, discover how Quanticate supported a biopharmaceutical sponsor with:
🔹 Integrated Summary of Safety delivery across four clinical trials
🔹 Pooled analysis of treatment-emergent safety outcomes
🔹 Harmonised safety endpoints, PK/PD data, and monitoring outputs
🔹 Evidence-led insights to support clinical monitoring and dose evaluation
📖 Read the full case study:
https://hubs.li/Q04ks13_0